NUCLEOLIN and colorectal carcinoma: For example, a combined strategy was used by Alibolandi et al. [187] that developed PEGylated poly(amidoamine) (PAMAM) dendrimers as carriers for camptothecin, which were further functionalized with AS1411 anti-nucleolin aptamers for achieving active-targeting nanosystems for CRC.